128 related articles for article (PubMed ID: 9061468)
1. Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.
Luo JP; Hubbard JW; Midha KK
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):303-8. PubMed ID: 9061468
[TBL] [Abstract][Full Text] [Related]
2. An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detection.
Midha KK; Cooper JK; Hawes EM; Hubbard JW; Korchinski ED; McKay G
Ther Drug Monit; 1988; 10(2):177-83. PubMed ID: 3381235
[TBL] [Abstract][Full Text] [Related]
3. An ultrasensitive method for the measurement of fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.
Cooper JK; Hawes EM; Hubbard JW; McKay G; Midha KK
Ther Drug Monit; 1989; 11(3):354-60. PubMed ID: 2728094
[TBL] [Abstract][Full Text] [Related]
4. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration.
Costello S; Heffron B; Taddei L; Benoit M; Hurt L; Simpson L; Bishop J; Folker-Calderon D; Negrusz A
J Anal Toxicol; 2013 Oct; 37(8):594-9. PubMed ID: 23986099
[TBL] [Abstract][Full Text] [Related]
6. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
7. Anodic coulometric detection with a glassy carbon electrode in combination with reversed-phase high-performance liquid chromatography. Determination of blood levels of perphenazine and fluphenazine.
Tjaden UR; Lankelma J; Poppe H
J Chromatogr; 1976 Sep; 125(1):275-86. PubMed ID: 977680
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
Chang SS; Javaid JI; Dysken MW; Casper RC; Janicak PG; Davis JM
Psychopharmacology (Berl); 1985; 87(1):55-8. PubMed ID: 3933037
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
[TBL] [Abstract][Full Text] [Related]
10. A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine.
Lo ES; Fein M; Hunter C; Suckow RF; Cooper TB
J Pharm Sci; 1988 Mar; 77(3):255-8. PubMed ID: 3373431
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of the depot antipsychotics.
Jann MW; Ereshefsky L; Saklad SR
Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.
Juenke JM; Brown PI; Urry FM; Johnson-Davis KL; McMillin GA
Clin Chim Acta; 2013 Aug; 423():32-4. PubMed ID: 23618971
[TBL] [Abstract][Full Text] [Related]
13. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
14. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
Jouen F; Verité P; André D; Colonna L; Boucly P
Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
[TBL] [Abstract][Full Text] [Related]
15. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector.
Javaid JI; Dekirmenjian H; Liskevych U; Lin RL; Davis JM
J Chromatogr Sci; 1981 Sep; 19(9):439-43. PubMed ID: 7298790
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Kissling W; Möller HJ; Walter K; Wittmann B; Krueger R; Trenk D
Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
[TBL] [Abstract][Full Text] [Related]
17. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710
[TBL] [Abstract][Full Text] [Related]
18. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
[TBL] [Abstract][Full Text] [Related]
19. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
Dreyfuss J; Shaw JM; Ross JJ
J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
